Stock Scorecard
Stock Summary for Scynexis Inc (SCYX) - $0.99 as of 9/17/2025 8:35:49 PM EST
Total Score
9 out of 30
Safety Score
27 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SCYX
Positive Quarterly and Annual earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the Annual earnings growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SCYX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SCYX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for SCYX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for SCYX (27 out of 100)
Stock Price Rating (Max of 10) | 1 |
Historical Stock Price Rating (Max of 10) | 4 |
Stock Price Trend (Max of 10) | 1 |
Book Value (Max of 10) | 2 |
Book Value to Price (Max of 10) | 8 |
Analyst Buy Ratings (Max of 5) | 3 |
Analyst Strong Buy Ratings (Max of 5) | 3 |
Dividend Yield Percentage (Max of 10) | 0 |
Operating Margin (Max of 10) | 0 |
Trading Volume (Max of 10) | 5 |
Price to Earnings (Max of 10) | 0 |
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for SCYX
Financial Details for SCYX
Company Overview |
|
---|---|
Ticker | SCYX |
Company Name | Scynexis Inc |
Country | USA |
Description | SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey. |
Sector Name | HEALTHCARE |
Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
Most Recent Quarter | 6/30/2025 |
Next Earnings Date | 11/5/2025 |
Stock Price History |
|
Last Day Price | 0.99 |
Price 4 Years Ago | 6.10 |
Last Day Price Updated | 9/17/2025 8:35:49 PM EST |
Last Day Volume | 391,256 |
Average Daily Volume | 220,849 |
52-Week High | 1.65 |
52-Week Low | 0.66 |
Last Price to 52 Week Low | 50.00% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 93.51 |
Sector PE | 40.64 |
5-Year Average PE | -1.99 |
Free Cash Flow Ratio | 3.81 |
Industry Free Cash Flow Ratio | 14.85 |
Sector Free Cash Flow Ratio | 29.51 |
Current Ratio Most Recent Quarter | 5.20 |
Total Cash Per Share | 0.26 |
Book Value Per Share Most Recent Quarter | 1.14 |
Price to Book Ratio | 1.06 |
Industry Price to Book Ratio | 12.19 |
Sector Price to Book Ratio | 32.14 |
Price to Sales Ratio Twelve Trailing Months | 14.16 |
Industry Price to Sales Ratio Twelve Trailing Months | 2.89 |
Sector Price to Sales Ratio Twelve Trailing Months | 19.15 |
Analyst Buy Ratings | 2 |
Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
Total Shares Outstanding | 41,924,900 |
Market Capitalization | 41,505,651 |
Institutional Ownership | 26.58% |
Dividends |
|
Ex-Dividend Date | N/A |
Previous Dividend Amount | 0.0000 |
Current Dividend Amount | 0.0000 |
Total Years Dividend Increasing | N/A |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | -131.75% |
Reported EPS 12 Trailing Months | -0.40 |
Reported EPS Past Year | -0.25 |
Reported EPS Prior Year | -0.44 |
Net Income Twelve Trailing Months | -19,517,000 |
Net Income Past Year | -21,288,000 |
Net Income Prior Year | 67,041,000 |
Quarterly Revenue Growth YOY | 85.30% |
5-Year Revenue Growth | 98.68% |
Operating Margin Twelve Trailing Months | -701.00% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 11,020,000 |
Total Cash Past Year | 16,051,000 |
Total Cash Prior Year | 34,050,000 |
Net Cash Position Most Recent Quarter | -1,139,000 |
Net Cash Position Past Year | 3,892,000 |
Long Term Debt Past Year | 12,159,000 |
Long Term Debt Prior Year | 12,159,000 |
Total Debt Most Recent Quarter | 12,159,000 |
Equity to Debt Ratio Past Year | 0.82 |
Equity to Debt Ratio Most Recent Quarter | 0.79 |
Total Stockholder Equity Past Year | 55,077,000 |
Total Stockholder Equity Prior Year | 72,962,000 |
Total Stockholder Equity Most Recent Quarter | 44,467,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | -24,102,000 |
Free Cash Flow Per Share Twelve Trailing Months | -0.57 |
Free Cash Flow Past Year | -24,009,000 |
Free Cash Flow Prior Year | 0 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 0.05 |
MACD Signal | 0.03 |
20-Day Bollinger Lower Band | 0.59 |
20-Day Bollinger Middle Band | 0.83 |
20-Day Bollinger Upper Band | 1.07 |
Beta | 1.75 |
RSI | 76.36 |
50-Day SMA | 1.03 |
150-Day SMA | 1.76 |
200-Day SMA | 2.24 |
System |
|
Modified | 9/16/2025 9:25:36 AM EST |